Influenza Virus Infections, Vaccines and Diagnosis
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Influenza Virus Vaccines".
Deadline for manuscript submissions: 31 March 2026 | Viewed by 2307
Special Issue Editors
Interests: influenza virus; monoclonal antibodies; vaccines; hepatitis C virus; HIV; JCV
Special Issues, Collections and Topics in MDPI journals
Interests: influenza virus; monoclonal antibodies; vaccines; hepatitis C virus; HIV; JCV
Special Issue Information
Dear Colleagues,
Despite seasonal vaccinations being an effective strategy for prevention, the influenza virus remains a significant public health issue, causing 3 to 5 million severe cases and up to 650,000 deaths each year. Concern arises from the virus’s ability to mutate and undergo genetic rearrangement, which leads to antigenic drift, antigenic shift, and spillovers from animal reservoirs. A notable example is the ongoing H5N1 avian influenza outbreak, which has resulted in widespread infections among poultry, wild birds, and mammals, including humans, and poses an increasing risk through human-to-human transmission. Although extensive research has been conducted on the influenza virus and vast amounts of data have been collected, critical gaps still need to be addressed in order to find a conclusive solution for this infection.
In this Special Issue, we encourage the submission of papers—such as research articles, case reports, and reviews—focused on recent advances in the field. We particularly welcome studies that examine host–pathogen relationships and the dynamics of innate and adaptive immune responses. We are also interested in developing novel and broadly effective prophylactic or therapeutic approaches to treat influenza.
Dr. Roberta Antonia Diotti
Dr. Isabel Pagani
Valeria Caputo
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- influenza
- avian influenza
- monoclonal antibodies
- vaccine
- therapy
- infection
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
